2018-05-16 11:19Press release

Gedea Biotech and Xintela nominated for this year’s SwedenBIO prize

The life science companies Gedea Biotech and Xintela, which belong to SmiLe Incubator in Lund, have been nominated for this year’s SwedenBIO Award. A jury will choose three finalists from the total of ten nominated companies at an event at Malmö City Hall.

SwedenBIO is the Swedish life science industry organization with more than 240 member companies active in the fields of pharma, biotech, medtech and diagnostics, as well as funding, intellectual property rights and legal affairs.

This year ten companies were nominated for the SwedenBIO Award, including Gedea Biotech, a member of SmiLe Incubator at Medicon Village in Lund, and Xintela, which was a member and is now an alumni member.

The nominees will be judged based on the following criteria:

  • a good reputation in the industry in general
  • extraordinary accomplishments regarding its own research and development, business development, growth or similar
  • contribution to societal benefit emphasizing the importance of a successful life science industry in Sweden
  • life science company that belongs to the SwedenBIO industry association

The winners will be selected by a jury that includes SwedenBIO’s board of directors and a representative from HealthCap, the sponsor of this year’s prize. The SwedenBIO Award is the industry’s own award and in addition to the honor, consists of a prize and the opportunity for two delegates to attend Nordic Life Science Days.

The ten nominated companies for the 2018 SwedenBIO Award are: Bioarctic, Galenica, Gedea Biotech, Hansa Medical, Ilya Pharma, Isconova/Novavax, Scandinavian Biopharma, Verigraft, Wilson Therapeutics and Xintela.

Previous winners include Alligator Biosciences, Cellavision, BioInvent, all from southern Sweden, and the major companies Recipharm and Vitrolife.



About Gedea Biotech: Gedea Biotech is developing an antibiotic-free, safe and effective treatment of vaginal fungal infections using a substance of natural origin to attack the cause of the disease in a novel way. http://www.gedeabiotech.com

About Xintela: Xintela is a biomedical company active in regenerative medicine and cancer with a focus on two areas with a great need for new and better treatment methods: joint damage and brain tumors. The company is listed on Nasdaq First North. www.xintela.se


For information about SmiLe Incubator, contact: Ebba Fåhraeus, CEO at SmiLe Incubator
+46 (0)734000433, 
ebba@smileincubator.life ; Or visit our mediaroom

Language: English

About SmiLe

SmiLe is a business incubator within life science based in Medicon Village in Lund. SmiLe helps entrepreneurs and startup companies to develop and commercialize new ideas. Our main task is to help the management teams of these companies to navigate the complexities of business development, financing, recruitment and risk management. There are currently 20+ companies in SmiLe, which together with alumni have attracted more than 175 MEUR in venture capital to date since 2014. Approximately 100 people, representing around 20 nationalities, and almost 50 percent of whom are women, work at SmiLe incubator. The opportunity also includes an acccelerator for early startups, Health2B, and an infrastructure that is unique of its kind in Sweden, with well-equipped laboratories and advanced instrumentation. SmiLe is also a community consisting of experts, business advisors, incubator companies as well as alumni companies, which when combined provide a unique opportunity for Life Science Industry startups to benefit from their extensive collective experience. SmiLe has its major financing from Lunds university, Lund Municipality, Region Skåne och Medicon Village.